Back
Astellas Pharma Vs. Nxera Pharma Industry Stock Comparison
Sell
34
ALPMY
Astellas Pharma
Last Price:
9.74
Seasonality Move:
0.67%
Sell
27
SOLTF
Nxera Pharma
Last Price:
9.82
Seasonality Move:
15.46%
Sell
34
Astellas Pharma (ALPMY)
is a Sell
Is Astellas Pharma a Buy, Sell or Hold?
- The current Astellas Pharma [ALPMY] share price is $9.90. The Score for ALPMY is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- ALPMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Nxera Pharma (SOLTF)
is a Sell
Is Nxera Pharma a Buy, Sell or Hold?
- The current Nxera Pharma [SOLTF] share price is $9.78. The Score for SOLTF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SOLTF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALPMY Stock Price Chart
What is Astellas Pharma's stock price today?
-
The Astellas Pharma share price today is $9.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SOLTF Stock Price Chart
What is Nxera Pharma's stock price today?
-
The Nxera Pharma share price today is $9.78
The current trend is relatively stagnant and SOLTF is experiencing slight buying pressure.
ALPMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 47.22 | Sell |
| Chaikin Money Flow: | 259604 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.42 - 10.18) | Buy |
| Bollinger Bands (100): | (10.13 - 11.67) | Sell |
SOLTF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 50.47 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.4 - 10.2) | Sell |
| Bollinger Bands (100): | (9.24 - 10.8) | Sell |
ALPMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.9 | Buy |
| 20-day SMA: | 9.65 | Buy |
| 50-day SMA: | 10.33 | Sell |
| 200-day SMA: | 12.24 | Sell |
| 8-day EMA: | 9.89 | Buy |
| 20-day EMA: | 9.89 | Buy |
| 50-day EMA: | 10.26 | Sell |
| 200-day EMA: | 11.87 | Sell |
SOLTF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.49 | Buy |
| 20-day SMA: | 9.66 | Buy |
| 50-day SMA: | 10.19 | Sell |
| 200-day SMA: | 10.24 | Sell |
| 8-day EMA: | 9.57 | Buy |
| 20-day EMA: | 9.69 | Buy |
| 50-day EMA: | 9.9 | Sell |
| 200-day EMA: | 10.82 | Sell |
Astellas Pharma Earnings Growth & ALPMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nxera Pharma Earnings Growth & SOLTF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Astellas Pharma Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nxera Pharma Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||